These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35418362)

  • 21. Staged tympanostomy tube placement facilitates pediatric cholesteatoma management.
    Mueller DT; Isaacson G
    Int J Pediatr Otorhinolaryngol; 2008 Feb; 72(2):167-71. PubMed ID: 18023884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analyses of the operative efficacy of 102 cases of acquired middle ear cholesteatoma].
    Yang B; Jiang X; Yang N; Hui L; Wang B; Sun Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):338-42. PubMed ID: 27220292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Invasive cholesteatoma of the old radical mastoidectomy].
    Portmann D; Moraes CL; Ribeiro S; Portmann M
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(2):99-104. PubMed ID: 14564824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pooled analysis of the evidence for open cavity, combined approach and reconstruction of the mastoid cavity in primary cholesteatoma surgery.
    Harris AT; Mettias B; Lesser TH
    J Laryngol Otol; 2016 Mar; 130(3):235-41. PubMed ID: 26878375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors of recidivism in pediatric cholesteatoma surgery.
    Ahn SH; Oh SH; Chang SO; Kim CS
    Int J Pediatr Otorhinolaryngol; 2003 Dec; 67(12):1325-30. PubMed ID: 14643476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iatrogenic cholesteatoma arising from the vascular strip.
    Sweeney AD; Hunter JB; Haynes DS; Driscoll CL; Rivas A; Vrabec JT; Carlson ML
    Laryngoscope; 2017 Mar; 127(3):698-701. PubMed ID: 27311645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactive glass granules for mastoid and epitympanic surgical obliteration: CT and MRI appearance.
    Bernardeschi D; Law-Ye B; Bielle F; Hochet B; Sterkers O; Dormont D; Pyatigorskaya N
    Eur Radiol; 2019 Oct; 29(10):5617-5626. PubMed ID: 30888487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canal wall up surgery with mastoid and epitympanic obliteration in acquired cholesteatoma.
    Hellingman CA; Geerse S; de Wolf MJF; Ebbens FA; van Spronsen E
    Laryngoscope; 2019 Apr; 129(4):981-985. PubMed ID: 30408197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of middle ear aeration on surgical outcome after intact canal wall tympanoplasty for cholesteatoma.
    Motegi M; Yamamoto Y; Ouchi K; Akutsu T; Tada T; Kurihara S; Takahashi M; Sampei S; Sano H; Morino T; Komori M; Yamamoto K; Sakurai Y; Kojima H
    Auris Nasus Larynx; 2020 Dec; 47(6):965-975. PubMed ID: 32646631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI, not CT, to rule out recurrent cholesteatoma and avoid unnecessary second-look mastoidectomy.
    Migirov L; Tal S; Eyal A; Kronenberg J
    Isr Med Assoc J; 2009 Mar; 11(3):144-6. PubMed ID: 19544702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total mastoid obliteration in staged canal-up tympanoplasty for cholesteatoma facilitates tympanic aeration.
    Yanagihara N; Komori M; Hinohira Y
    Otol Neurotol; 2009 Sep; 30(6):766-70. PubMed ID: 19704361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canal wall-down mastoidectomy with mastoid obliteration for pediatric cholesteatoma.
    Sun J; Sun J; Hu Y; Lv Q; Wang Y; Li X; Xu W; Wang S; Mei Z; Wan G
    Acta Otolaryngol; 2010 Feb; 130(2):259-62. PubMed ID: 19565369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and pathological features of cholesteatoma in young children].
    Skotnicka B; Hassmann-Poznańska E
    Otolaryngol Pol; 2010; 64(6):375-81. PubMed ID: 21302505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of temporal subtraction computed tomography and non-echoplanar diffusion-weighted imaging for the mastoid extension of middle ear cholesteatoma.
    Baba A; Kurihara S; Kurokawa R; Kurokawa M; Ota Y; Matsushima S; Fukuda T; Yamauchi H; Kano R; Shoji T; Nakazawa T; Yamamoto Y; Kojima H; Srinivasan A; Ojiri H
    Auris Nasus Larynx; 2022 Dec; 49(6):956-963. PubMed ID: 35341626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Mastoid Function with Magnetic Resonance Imaging after Canal Wall Up Cholesteatoma Surgery.
    Parkes WJ; Cushing SL; Papsin BC; Blaser SI; James AL
    J Int Adv Otol; 2016 Aug; 12(2):132-136. PubMed ID: 27716596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital cholesteatoma: Clinical features and surgical outcomes.
    Reuven Y; Raveh E; Ulanovski D; Hilly O; Kornreich L; Sokolov M
    Int J Pediatr Otorhinolaryngol; 2022 May; 156():111098. PubMed ID: 35255443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mastoid obliteration for pediatric suppurative cholesteatoma: long-term safety and sustained effectiveness after 30 years' experience with cartilage obliteration.
    Kuo CL; Lien CF; Shiao AS
    Audiol Neurootol; 2014; 19(6):358-69. PubMed ID: 25377728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidimensional staging system for pediatric acquired cholesteatoma: A 30-year verification data.
    Kuo CL; Shiao AS; Chen CH; Lien CF
    Auris Nasus Larynx; 2016 Aug; 43(4):387-94. PubMed ID: 26443626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycological study on cholesteatoma keratin obtained during primary mastoid surgery.
    Effat KG; Madany NM
    J Laryngol Otol; 2014 Oct; 128(10):881-4. PubMed ID: 25236688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results.
    Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S
    Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.